Overview

A Study Evaluating Safety and Efficacy of BIOD 531 Compared to Humalog® Mix 75/25 in Subjects With Type 2 Diabetes

Status:
Suspended
Trial end date:
2016-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of BIOD-531 compared to Humalog®Mix 75/25 in patients with type 2 diabetes.
Phase:
Phase 2
Details
Lead Sponsor:
Biodel
Treatments:
Biphasic Insulins
Insulin Lispro
Insulin, Isophane